They suggested that either EGFR tyrosine kinase inhibitor or AKT inhibitor abrogated radiation-induced DNA-PKcs phosphorylation at Thr2609 in K-RAS mutated tumor cells. This evidence concerns the gene EGFR and neoplasm.